Regenerx Biopharmaceuticals Inc
RGRXDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000707511
Regenerx Biopharmaceuticals Inc was delisted in 2023; its insiders filed their last Form 4 on Jul 6, 2023; 1 institution reported holding it in 13F filings for Q3 2023, worth $170 in total; no superinvestor held it.
Holders of 5% or more of RGRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Regenerx Biopharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Regenerx Biopharmaceuticals Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Regenerx Biopharmaceuticals Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 6, 2023 | Essetifin SPA | 13D/AOld format | – | – | – | SEC |
| Jul 2, 2021 | Essetifin SPA | 13D/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Regenerx Biopharmaceuticals Inc shares.
No Form 144 notices for Regenerx Biopharmaceuticals Inc are on file.